Bishoy Morris Faltas, M.D., is an Assistant Professor of Medicine at Weill Cornell Medicine and an Assistant Attending in the Genitourinary Oncology Program in the Division of Hematology & Medical Oncology. Dr. Faltas completed his Hematology and Medical Oncology Fellowship at Weill Cornell Medicine, as well as additional training through a research fellowship in the laboratory of EIPM’s founder, Dr. Mark A. Rubin. During this time, he led studies of the clonal evolution and the neoantigenic structure of platinum-resistant bladder cancer. As a physician-scientist, Dr. Faltas conducts research focusing on understanding the molecular profiles of metastatic platinum-resistant urothelial bladder cancer. His research focus is on the mechanisms of mutagenesis and drug-resistance in bladder carcinoma, as well as immunogenomic studies of urological malignancies. By understanding the molecular changes that occur as urothelial cancer evolves under the effect of chemotherapy and metastatic spread, Dr. Faltas aims to identify potential drug targets for translation into therapeutic clinical trials. In addition to authoring many peer-reviewed journal articles, Dr. Faltas is the recipient of several research awards, including the Scott-Wadler Fellow Research award and the Weill Department of Medicine Fellow Award in Research. He has also received the NIH/NCATS CTSC KL2 Scholar grant, the American Society of Clinical Oncology Conquer Cancer Foundation Young Investigator Award and the Department of Defense Career Development Award.